Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$4.30 USD
-0.66 (-13.23%)
Updated May 21, 2024 03:59 PM ET
After-Market: $4.29 -0.01 (-0.12%) 7:08 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
Monte Rosa Therapeutics, Inc. [GLUE]
Reports for Purchase
Showing records 1 - 5 ( 5 total )
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; Stay Glued for MRT-2359 Updates Ahead
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM and $11 PT: The QuEEN of Monte Rosa
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Monte Rosa Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Learnings From FASEBs Ubiquitin Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
|